Status | Study |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas Condition: Basal Cell Carcinomas Date: 2016-07-01 Interventions: Drug: patidegib gel 2% - cohort 1 |
Completed |
Study Name: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients Condition: Basal Cell Nevus Syndrome Date: 2016-04-27 Interventions: Drug: patidegib patidegib gel |
Recruiting |
Study Name: Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2015-12-14 Interventions: Drug: Vismodegib Vismodegib 150 mgs po qd for 3 months |
Recruiting |
Study Name: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Condition: Basal Cell Nevus Syndrome Skin Neoplasm Date: 2015-09-10 Interventions: Biological: ASN-002 ASN‐ |
Recruiting |
Study Name: Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) Condition: Basal Cell Carcinoma in Basal Cell Nevus Syndrome Date: 2015-01-21 Interventions: Drug: SUBA-Itraconazole Subjects will receive an oral dose of 300 mg SUBA-Itraconazole daily. |
Active, not recruiting |
Study Name: Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Condition: Basal Cell Carcinoma of the Skin Nevoid Basal Cell Carcinoma Syndrome Date: 2014-11-25 Interventions: Drug: Buparlisib Given PO |
Active, not recruiting |
Study Name: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome Condition: Basal Cell Carcinoma of the Skin Nevoid Basal Cell Carcinoma Syndrome Date: 2014-10-03 Interventions: Drug: aminolevulinic acid hydrochloride |
Completed |
Study Name: Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Condition: Basal Cell Nevus Syndrome Date: 2014-06-02 Interventions: Drug: Levulan Levulan applicat |
Active, not recruiting |
Study Name: Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome Condition: Basal Cell Nevus Syndrome Date: 2014-02-28 Interventions: Drug: BMS-833923 BMS-833923, by mouth, at the dose and schedule administered while enrolled in CA194002. |